Coronvirus: Drugs

Department of Health and Social Care written question – answered on 17th January 2022.

Alert me about debates like this

Photo of Daisy Cooper Daisy Cooper Liberal Democrat Spokesperson (Health and Social Care)

To ask the Secretary of State for Health and Social Care, in what way (a) clinicians, (b) patient groups, (c) hon. Members and (d) others can make representations to the relevant NHS unit about including additional individual patients or groups of patients who might be considered to be eligible to receive covid-19 antiviral treatments, who are currently not considered eligible.

Photo of Maggie Throup Maggie Throup The Parliamentary Under-Secretary for Health and Social Care

The cohorts eligible for treatment with antivirals and monoclonal antibodies have been determined by an independent expert group commissioned by the Department and included in a clinical policy agreed by the United Kingdom Chief Medical Officers. This was created based on evidence that certain health conditions can make a patient much more likely to progress to severe disease. As a result, these patients could benefit the most from novel medications.

We are currently reviewing a process for considering changes to this cohort and an update will be available shortly. In the meantime, if a patient believes they may be eligible to access these treatments, they are advised to contact their general practitioner or consultant or NHS 111.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.